Table of Contents
Licensing
| Astellas Pays US$300 M Upfront to Access Immunomic’s LAMP-vax™ Platform | Abstract html |
| Heather Cartwright & Sayani Datta |
| Novartis Comes to the Rescue of Xoma with TGFb Antibody Licensing Deal | Abstract pdf html |
| Heather Cartwright & Keshav Mahawar |
Mergers & Acquisitions
| BioMarin Exits Oncology Sector by Selling Talazoparib to Medivation in US$570 M Deal | Abstract html |
| Heather Cartwright & Sayani Datta |
| BMS Fuels its Fibrotic Disease Pipeline with US$1.25 B Deal for Promedior | Abstract html |
| Heather Cartwright & Sayani Datta |
This work is licensed under a Creative Commons Attribution 3.0 License.